Nivolumab,Doxorubicin,Vinblastine,dacarbazine 
BMS
['nivo', 'lymsm', 'nivolumab']
nivahl #ash22 #lymsm
a thoughtful discussion by &amp; coop about where to next. will pd1i alone be enough to cure ipet-negative patients? a bold approach which dr br ckelmann emphasises is aimed at prioritising time-limited therapy.
cc 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer